Novo Nordisk | Passifs Courants



Current Liabilities Changement Date
ANI Pharmaceuticals USD 236.83M 35.02M 2025-06
Aurora Cannabis CAD 156.88M 7.07M 2025-06
Bausch Health Companies USD 4.98B 719M 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Canopy Growth CAD 98.67M 1.65M 2025-06
Corcept Therapeutics USD 144.66M 1.6M 2025-06
Drreddys Laboratories INR 142.59B 10.64B 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
GlaxoSmithKline GBP 20.38B 453M 2025-06
Merck USD 26.04B 863M 2025-06
Novartis USD 31.71B 95M 2025-06
Novo Nordisk 207.52B 28.6B 2025-06
Novo Nordisk DKK 236.12B 27.76B 2025-03
Pacira USD 313.16M 1.57M 2025-06
Perrigo USD 1.13B 52.3M 2025-06
Prestige Brands USD 109.67M 3.04M 2025-06
Sanofi 29.06B 3.16B 2025-06
Supernus Pharmaceuticals USD 286.36M 4.59M 2025-06
Zoetis USD 3.37B 19M 2025-06


Novo Nordisk Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.